Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Authors
Keywords
-
Journal
MOLECULES
Volume 20, Issue 1, Pages 1304-1318
Publisher
MDPI AG
Online
2015-01-14
DOI
10.3390/molecules20011304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
- (2014) M. Carreiras et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Multifunctional Tacrine Derivatives in Alzheimer’s Disease
- (2014) Anna Minarini et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease
- (2014) Xiaoming Qiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease
- (2013) Yan He et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease
- (2013) Chuanjun Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: Multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation
- (2012) Fei Mao et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Effect of Paeonol on Antioxidant and Immune Regulatory Activity in Hepatocellular Carcinoma Rats
- (2012) Bendong Chen et al. MOLECULES
- Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer's disease
- (2011) Jun Zhou et al. BRAIN RESEARCH
- Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors
- (2011) Cunlong Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD
- (2011) Rainer Hellweg et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
- (2011) Rafael León et al. MEDICINAL RESEARCH REVIEWS
- Synthesis, Characterization, Acetylcholinesterase Inhibition, Molecular Modeling and Antioxidant Activities of Some Novel Schiff Bases Derived from 1-(2-Ketoiminoethyl)piperazines
- (2011) Saleh M. Salga et al. MOLECULES
- Paeonol Prevents Excitotoxicity in Rat Pheochromocytoma PC12 Cells via Downregulation of ERK Activation and Inhibition of Apoptosis
- (2011) Xuncui Wang et al. PLANTA MEDICA
- Paeonol Attenuates Microglia-Mediated Inflammation and Oxidative Stress–Induced Neurotoxicity in Rat Primary Microglia and Cortical Neurons
- (2011) Yu-Ting Tseng et al. SHOCK
- Neuroprotective therapeutics for Alzheimer's disease: progress and prospects
- (2011) Alan M. Palmer TRENDS IN PHARMACOLOGICAL SCIENCES
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cholinesterase Inhibitors and Beyond
- (2009) Giancarlo Pepeu et al. Current Alzheimer Research
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice
- (2008) Shu-Zhi Zhong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started